UnitedHealth Group (UNH) Competitors

$377.48 -10.99 (-2.83%)

As of 05/26/2026 03:58 PM Eastern

UNH vs. ALKS, MEDP, CI, CNC, and CVS

Should you buy UnitedHealth Group stock or one of its competitors? MarketBeat compares UnitedHealth Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UnitedHealth Group include Alkermes (ALKS), Medpace (MEDP), Cigna Group (CI), Centene (CNC), and CVS Health (CVS). These companies are all part of the "medical" sector.

How does UnitedHealth Group compare to Alkermes?

Alkermes (NASDAQ:ALKS) and UnitedHealth Group (NYSE:UNH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

UnitedHealth Group has higher revenue and earnings than Alkermes. UnitedHealth Group is trading at a lower price-to-earnings ratio than Alkermes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alkermes	$1.48B	4.22	$241.66M	$0.90	41.50
UnitedHealth Group	$447.57B	0.77	$12.06B	$13.24	28.51

95.2% of Alkermes shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 4.6% of Alkermes shares are owned by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Alkermes has a net margin of 9.78% compared to UnitedHealth Group's net margin of 2.68%. UnitedHealth Group's return on equity of 14.65% beat Alkermes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alkermes	9.78%	9.26%	5.66%
UnitedHealth Group	2.68%	14.65%	4.77%

Alkermes has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

Alkermes currently has a consensus target price of $45.40, suggesting a potential upside of 21.55%. UnitedHealth Group has a consensus target price of $390.00, suggesting a potential upside of 3.32%. Given Alkermes' stronger consensus rating and higher probable upside, analysts plainly believe Alkermes is more favorable than UnitedHealth Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alkermes	0 Sell rating(s)	5 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.76
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74

In the previous week, UnitedHealth Group had 71 more articles in the media than Alkermes. MarketBeat recorded 78 mentions for UnitedHealth Group and 7 mentions for Alkermes. UnitedHealth Group's average media sentiment score of 1.18 beat Alkermes' score of 0.49 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alkermes	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
UnitedHealth Group	52 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Alkermes and UnitedHealth Group tied by winning 8 of the 16 factors compared between the two stocks.

How does UnitedHealth Group compare to Medpace?

UnitedHealth Group (NYSE:UNH) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Medpace has a net margin of 17.19% compared to UnitedHealth Group's net margin of 2.68%. Medpace's return on equity of 120.89% beat UnitedHealth Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UnitedHealth Group	2.68%	14.65%	4.77%
Medpace	17.19%	120.89%	24.79%

UnitedHealth Group has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, Medpace has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of UnitedHealth Group shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

UnitedHealth Group has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UnitedHealth Group	$447.57B	0.77	$12.06B	$13.24	28.51
Medpace	$2.68B	4.58	$451.12M	$15.91	26.97

In the previous week, UnitedHealth Group had 49 more articles in the media than Medpace. MarketBeat recorded 78 mentions for UnitedHealth Group and 29 mentions for Medpace. UnitedHealth Group's average media sentiment score of 1.18 beat Medpace's score of 0.17 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UnitedHealth Group	52 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	3 Very Positive mention(s)	0 Positive mention(s)	26 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

UnitedHealth Group presently has a consensus price target of $390.00, suggesting a potential upside of 3.32%. Medpace has a consensus price target of $467.08, suggesting a potential upside of 8.85%. Given Medpace's higher possible upside, analysts plainly believe Medpace is more favorable than UnitedHealth Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

UnitedHealth Group beats Medpace on 9 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to Cigna Group?

Cigna Group (NYSE:CI) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

UnitedHealth Group has a net margin of 2.68% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat UnitedHealth Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
UnitedHealth Group	2.68%	14.65%	4.77%

UnitedHealth Group has higher revenue and earnings than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.27	$5.96B	$23.59	11.92
UnitedHealth Group	$447.57B	0.77	$12.06B	$13.24	28.51

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.3%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years and UnitedHealth Group has increased its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, UnitedHealth Group had 60 more articles in the media than Cigna Group. MarketBeat recorded 78 mentions for UnitedHealth Group and 18 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.29 beat UnitedHealth Group's score of 1.18 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	14 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UnitedHealth Group	52 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group currently has a consensus target price of $339.50, indicating a potential upside of 20.72%. UnitedHealth Group has a consensus target price of $390.00, indicating a potential upside of 3.32%. Given Cigna Group's stronger consensus rating and higher probable upside, equities analysts clearly believe Cigna Group is more favorable than UnitedHealth Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	6 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.76
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by insiders. Comparatively, 0.3% of UnitedHealth Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Cigna Group has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

Summary

UnitedHealth Group beats Cigna Group on 11 of the 19 factors compared between the two stocks.

How does UnitedHealth Group compare to Centene?

UnitedHealth Group (NYSE:UNH) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of UnitedHealth Group shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

UnitedHealth Group has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Centene has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market.

UnitedHealth Group has a net margin of 2.68% compared to Centene's net margin of -3.25%. UnitedHealth Group's return on equity of 14.65% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UnitedHealth Group	2.68%	14.65%	4.77%
Centene	-3.25%	5.57%	1.54%

UnitedHealth Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UnitedHealth Group	$447.57B	0.77	$12.06B	$13.24	28.51
Centene	$194.78B	0.14	-$6.67B	-$13.14	N/A

In the previous week, UnitedHealth Group had 73 more articles in the media than Centene. MarketBeat recorded 78 mentions for UnitedHealth Group and 5 mentions for Centene. UnitedHealth Group's average media sentiment score of 1.18 beat Centene's score of 0.57 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UnitedHealth Group	52 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UnitedHealth Group presently has a consensus target price of $390.00, suggesting a potential upside of 3.32%. Centene has a consensus target price of $57.65, suggesting a potential upside of 0.80%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts plainly believe UnitedHealth Group is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74
Centene	2 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.37

Summary

UnitedHealth Group beats Centene on 13 of the 16 factors compared between the two stocks.

How does UnitedHealth Group compare to CVS Health?

UnitedHealth Group (NYSE:UNH) and CVS Health (NYSE:CVS) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.3%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.9%. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. CVS Health pays out 117.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UnitedHealth Group has increased its dividend for 15 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

In the previous week, UnitedHealth Group had 21 more articles in the media than CVS Health. MarketBeat recorded 78 mentions for UnitedHealth Group and 57 mentions for CVS Health. UnitedHealth Group's average media sentiment score of 1.18 beat CVS Health's score of 0.84 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UnitedHealth Group	52 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
CVS Health	35 Very Positive mention(s)	9 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

UnitedHealth Group currently has a consensus price target of $390.00, suggesting a potential upside of 3.32%. CVS Health has a consensus price target of $98.88, suggesting a potential upside of 8.73%. Given CVS Health's stronger consensus rating and higher probable upside, analysts plainly believe CVS Health is more favorable than UnitedHealth Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74
CVS Health	0 Sell rating(s)	4 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.85

87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.3% of UnitedHealth Group shares are owned by company insiders. Comparatively, 0.9% of CVS Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

UnitedHealth Group has higher revenue and earnings than CVS Health. UnitedHealth Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UnitedHealth Group	$447.57B	0.77	$12.06B	$13.24	28.51
CVS Health	$402.07B	0.29	$1.77B	$2.27	40.06

UnitedHealth Group has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

UnitedHealth Group has a net margin of 2.68% compared to CVS Health's net margin of 0.72%. UnitedHealth Group's return on equity of 14.65% beat CVS Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UnitedHealth Group	2.68%	14.65%	4.77%
CVS Health	0.72%	11.88%	3.54%

Summary

UnitedHealth Group beats CVS Health on 14 of the 20 factors compared between the two stocks.

Get UnitedHealth Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UNH vs. The Competition

Export

Metric	UnitedHealth Group	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$352.79B	$50.65B	$6.46B	$23.18B
Dividend Yield	2.28%	1.78%	2.76%	4.09%
P/E Ratio	28.51	22.60	21.07	31.06
Price / Sales	0.77	0.63	555.74	24.64
Price / Cash	18.27	23.22	43.49	25.06
Price / Book	3.30	2.51	10.36	4.78
Net Income	$12.06B	$1.46B	$3.56B	$1.07B
7 Day Performance	-1.52%	1.80%	2.34%	1.74%
1 Month Performance	6.44%	9.64%	2.03%	1.35%
1 Year Performance	27.96%	-9.12%	35.50%	27.44%

UnitedHealth Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UNH UnitedHealth Group	4.2722 of 5 stars	$377.48 -2.8%	$390.00 +3.3%	+27.8%	$352.79B	$447.57B	28.51	390,000	Positive News Analyst Forecast
ALKS Alkermes	3.0237 of 5 stars	$36.95 -0.1%	$45.40 +22.9%	+27.3%	$6.16B	$1.48B	41.06	2,050
MEDP Medpace	2.9343 of 5 stars	$430.10 +2.0%	$467.08 +8.6%	+45.5%	$12.28B	$2.53B	27.03	6,200	Trending News
CI Cigna Group	4.9564 of 5 stars	$281.84 -0.4%	$338.55 +20.1%	-11.1%	$74.56B	$274.90B	11.95	67,700	Positive News Analyst Forecast
CNC Centene	3.3246 of 5 stars	$57.72 -1.0%	$56.59 -2.0%	+1.4%	$28.50B	$194.78B	N/A	61,100	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:UNH) was last updated on 5/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Competitors

UNH vs. ALKS, MEDP, CI, CNC, and CVS

How does UnitedHealth Group compare to Alkermes?

Summary

How does UnitedHealth Group compare to Medpace?

Summary

How does UnitedHealth Group compare to Cigna Group?

Summary

How does UnitedHealth Group compare to Centene?

Summary

How does UnitedHealth Group compare to CVS Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UNH vs. The Competition

UnitedHealth Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UnitedHealth Group (UNH) Competitors

UNH vs. ALKS, MEDP, CI, CNC, and CVS

How does UnitedHealth Group compare to Alkermes?

Which has preferable valuation & earnings, ALKS or UNH?

Do insiders and institutionals hold more shares of ALKS or UNH?

Is ALKS or UNH more profitable?

Which has more risk and volatility, ALKS or UNH?

Do analysts rate ALKS or UNH?

Does the media prefer ALKS or UNH?

Summary

How does UnitedHealth Group compare to Medpace?

Is UNH or MEDP more profitable?

Which has more volatility & risk, UNH or MEDP?

Do institutionals and insiders have more ownership in UNH or MEDP?

Which has stronger valuation and earnings, UNH or MEDP?

Does the media refer more to UNH or MEDP?

Do analysts rate UNH or MEDP?

Summary

How does UnitedHealth Group compare to Cigna Group?

Is CI or UNH more profitable?

Which has higher earnings and valuation, CI or UNH?

Is CI or UNH a better dividend stock?

Does the media prefer CI or UNH?

Do analysts prefer CI or UNH?

Do institutionals and insiders believe in CI or UNH?

Which has more volatility and risk, CI or UNH?

Summary

How does UnitedHealth Group compare to Centene?

Do institutionals and insiders hold more shares of UNH or CNC?

Which has more volatility & risk, UNH or CNC?

Is UNH or CNC more profitable?

Which has better valuation and earnings, UNH or CNC?

Does the media favor UNH or CNC?

Do analysts recommend UNH or CNC?

Summary

How does UnitedHealth Group compare to CVS Health?

Is UNH or CVS a better dividend stock?

Does the media favor UNH or CVS?

Do analysts prefer UNH or CVS?

Do institutionals & insiders believe in UNH or CVS?

Which has preferable valuation & earnings, UNH or CVS?

Which has more volatility and risk, UNH or CVS?

Is UNH or CVS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UNH vs. The Competition

UnitedHealth Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools